Jade Biosciences annual return on equity
2021
2022
2023
2024
2025
Jade Biosciences Return on Equity (ROE) Growth & History (JBIO)
Jade Biosciences's return on equity was −89.19% for fiscal 2025.
View full Jade Biosciences company overviewJade Biosciences annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −89.19% | +133.07 pp |
| 2024 | 2024-12-31 | −222.25% | −158.30 pp |
| 2023 | 2023-12-31 | −63.95% | −29.51 pp |
| 2022 | 2022-12-31 | −34.44% | −5.57 pp |
| 2021 | 2021-12-31 | −28.87% | — |
Jade Biosciences quarterly return on equity
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −15.15% | +39.30 pp |
| Q1 2026 | 2026-03-31 | −12.84% | — |
| Q4 2025 | 2025-12-31 | −12.48% | — |
| Q3 2025 | 2025-09-30 | −13.22% | +28.77 pp |
| Q2 2025 | 2025-06-30 | −54.44% | −27.70 pp |
| Q3 2024 | 2024-09-30 | −41.99% | −27.37 pp |
| Q2 2024 | 2024-06-30 | −26.74% | −11.82 pp |
| Q1 2024 | 2024-03-31 | −23.14% | −9.37 pp |
| Q4 2023 | 2023-12-31 | −17.36% | −6.06 pp |
| Q3 2023 | 2023-09-30 | −14.62% | −5.25 pp |
| Q2 2023 | 2023-06-30 | −14.92% | −7.26 pp |
| Q1 2023 | 2023-03-31 | −13.78% | −7.25 pp |
| Q4 2022 | 2022-12-31 | −11.30% | −6.63 pp |
| Q3 2022 | 2022-09-30 | −9.36% | −1.55 pp |
| Q2 2022 | 2022-06-30 | −7.66% | — |
| Q1 2022 | 2022-03-31 | −6.53% | — |
| Q4 2021 | 2021-12-31 | −4.67% | — |
| Q3 2021 | 2021-09-30 | −7.81% | — |
Jade Biosciences return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, Jade Biosciences's return on equity decreased from −28.87% to −89.19%, a change of −60.31 percentage points. The latest reported quarter, Q2 2026, shows −15.15%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Jade Biosciences source filings ↗